Table 3.
Tumor response rates of intention-to-treat population
| Response | Cilengitide 240 mg/m2 n = 35 | Cilengitide 400 mg/m2 n = 35 | Cilengitide 600 mg/m2 n = 36 | Docetaxel 75 mg/m2 n = 34 |
|---|---|---|---|---|
| Complete response, n | 0 | 0 | 0 | 0 |
| Partial response, n (%) | 0 | 0 | 0 | 5a (15) |
| Stable disease, n (%) | 7 (20) | 3 (9) | 7 (19) | 11 (32) |
| Progressive disease, n (%) | 17 (49) | 26 (74) | 23 (64) | 12 (35) |
| Response rate, % | 0 | 0 | 0 | 15 |
| Tumor growth control, % | 20 | 9 | 19 | 47 |
aTwo of these five partial responses were not confirmed according to Response Evaluation Criteria In Solid Tumors (RECIST)